Previous 10 | Next 10 |
Gainers: Sonoma Pharmaceuticals (NASDAQ: SNOA ) +145% . More news on: Sonoma Pharmaceuticals, Inc., Adaptimmune Therapeutics plc, Phio Pharmaceuticals Corp., Stocks on the move, , Read more ...
LEXINGTON, Mass. , May 29, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infections, announced the American Society of Clinical Oncology (ASCO2020) Virtual Scientific Pro...
May 28, 2020 Palm Beach, FL – May 28, 2020 – Glioblastoma is a type of brain cancer. It’s the most common type of malignant brain tumor among adults. And it is usually very aggressive, which means it can grow fast and spread quickly. Glioblastoma multiforme is...
Agenus ( AGEN ) is a pharmaceutical company focused on immunotherapies. Its current lead candidates are balstilimab, which has the same target, PD-1, as Opdivo and Keytruda, and zalifrelimab, which has the same CTLA-4 target as Yervoy. Agenus can claim to have a larger cancer immunotherapy pip...
LEXINGTON, Mass. , May 14, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infections, announced today that it will present data on AGEN1181 at the American Society of Clin...
LEXINGTON, Mass. , May 13, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announced today the FDA acceptance of the IND application for an alloge...
Image source: The Motley Fool. Agenus Inc (NASDAQ: AGEN) Q1 2020 Earnings Call May 8, 2020 , 8:30 p.m. ET Operator Continue reading
Agenus Inc. (AGEN) Q1 2020 Results Conference Call May 07, 2020 08:30 AM ET Company Participants Dr. Jennifer Buell - President and COO Dr. Garo Armen - Chairman and CEO Dhan Chand - Head, Drug Discovery Christine Klaskin - VP, Finance Conference Call Participants Mayank ...
The following slide deck was published by Agenus Inc. in conjunction with their 2020 Q1 earnings Read more ...
Agenus ( AGEN -7.0% ) Q1 results : More news on: Agenus Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its second quarter 2024 financial results before the market opens on Thursday, August 8, 2024. Agenus executives will host a co...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
2024-07-18 12:11:22 ET Agenus Inc (NASDAQ: AGEN) faced a dramatic decline in its stock price on Thursday, plummeting more than 50%, following the US Food and Drug Administration (FDA’s) decision to advise against pursuing accelerated approval for its BOT/BAL colorectal cance...